Misuse of Drugs Act 1975

Schedule 3
Class C controlled drugs

s 2(1)

Part 1

  • 1 Cannabis fruit

    Cannabis plant (whether fresh, dried, or otherwise)—that is, any part of any plant of the genus Cannabis except a part from which all the resin has been extracted

    Cannabis seed

    Catha edulis plant

    Coca leaf—that is, the leaf of any plant of any species of the genus Erythroxylon, except a leaf from which all ecgonine, cocaine, and any other ecgonine alkaloids have been removed.

    Schedule 3 Part 1 clause 1 Cannabis plant: amended, on 13 January 1983, by section 8 of the Misuse of Drugs Amendment Act 1982 (1982 No 151).

    Schedule 3 Part 1 clause 1 Catha edulis plant: inserted, on 21 May 1981, by clause 4 of the Misuse of Drugs Order 1981 (SR 1981/114).

  • 2 The following substances:

    BZP (1-benzylpiperazine or A2 benzylpiperazine or N-benzylpiperazine (1-benzyl-1,4-diazacyclohexane))

    TFMPP (1-(3-trifluoromethylphenyl)piperazine or N-(3-trifluoromethylphenyl)piperazine)

    pFPP (1-(4-fluorophenyl)piperazine)

    MeOPP (1-(4-methoxyphenyl)piperazine)

    mCPP (1-(meta-chlorophenyl)piperazine) or 1-(3-chlorophenyl)piperazine)

    MBZP (1-methyl-4-benzylpiperazine).

    Schedule 3 Part 1 clause 2: inserted, on 1 April 2008, by section 4 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).

  • 3 The isomers of the substances mentioned in clause 2 whenever the existence of such isomers is possible within the specific chemical designation.

    Schedule 3 Part 1 clause 3: inserted, on 1 April 2008, by section 4 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).

  • 4 The esters and ethers of the substances mentioned in clause 2 and the esters and the ethers of the isomers mentioned in clause 3 whenever the existence of such esters or ethers is possible.

    Schedule 3 Part 1 clause 4: inserted, on 1 April 2008, by section 4 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).

  • 5 The salts of the substances mentioned in clause 2 and the salts of the isomers, esters, and ethers mentioned in clause 3 or 4.

    Schedule 3 Part 1 clause 5: inserted, on 1 April 2008, by section 4 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).

  • 6 Substances containing any proportion of a substance mentioned in clause 2, 3, 4, or 5.

    Schedule 3 Part 1 clause 6: inserted, on 1 April 2008, by section 4 of the Misuse of Drugs (Classification of BZP) Amendment Act 2008 (2008 No 5).

Part 2

Codeine (3-methylmorphine); its isomers, esters, and ethers, if any; its salts, and the salts of its isomers, esters, or ethers, if any; and any substance, preparation or mixture containing any proportion of the said substance or of any such isomer, ester, ether, or salt, other than a preparation or mixture named or described in Part 6

Dihydrocodeine; its isomers, esters, and ethers, if any; its salts, and the salts of its isomers, esters, or ethers, if any; and any substance, preparation, or mixture containing any proportion of the said substance or of any such isomer, ester, ether, or salt, other than a preparation or mixture named or described in Part 6

Propoxyphene (α-4 (N, N-dimethylamino)-1, 2-diphenyl-3-methyl-2-propionoxybutane); its isomers, esters, and ethers, if any; its salts and the salts of its isomers, esters, or ethers, if any; except in preparations of propoxyphene described in clause 5A of Part 5.

  • Schedule 3 Part 2 Dihydrocodeine: inserted, on 2 September 1996, by section 8(1) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

  • Schedule 3 Part 2 Dihydrocodeine amended, on 15 November 2000, by section 10 of the Misuse of Drugs Amendment Act 2000 (2000 No 47).

  • Schedule 3 Part 2 Propoxyphene: replaced, on 20 December 1984, by clause 2(1) of the Misuse of Drugs Order (No 2) 1984 (SR 1984/315).

Part 3

1 The following substances, namely:
  • Acetyldihydrocodeine

    Ethylmorphine (3-ethylmorphine)

    Nicocodine (6-nicotinylcodeine)

    Nicodicodine (6-nicotinyldihydrocodeine or nicotinic acid ester of dihydrocodeine)

    Norcodeine (N-demethylcodeine)

    Pholcodine (morpholinylethylmorphine)

    Propiram (N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide).

    Schedule 3 Part 3 clause 1 Dihydrocodeine: repealed, on 2 September 1996, by section 8(2) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

  • 2 The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

  • 3 The esters and ethers of the substances mentioned in this Part and the esters and the ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

  • 4 The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

  • 5 Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4, other than a preparation or mixture named or described in Part 6.

6
  • [Repealed]

    Schedule 3 Part 3 clause 6: repealed, on 8 September 2011, by section 9(1) of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

Part 4

1 The following substances, namely:
  • Allobarbital (5,5-diallylbarbituric acid)

    Amobarbital (5-ethyl-5-(3-methylbutyl) barbituric acid)

    Buprenorphine (17-cyclopropylmethyl-7,8-dihydro-7-(1-hydroxy-1,2, 2-trimethylpropyl) -6-0-methyl-6, 14-ethano-17-normorphine)

    Butalbital (5-allyl-5-isobutylbarbituric acid)

    Butobarbitone (5-butyl-5-ethylbarbituric acid)

    Cyclobarbital (5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid)

    Glutethimide (2-ethyl-2-phenylglutarimide)

    Ketamine (2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone)

    Nealbarbitone (5-allyl-5-neopentylbarbituric acid)

    Pentobarbital (5-ethyl-5-(1-methylbutyl) barbituric acid)

    Secbutabarbital (5-sec-butyl-5-ethylbarbituric acid)

    Secobarbital (5-allyl-5-(1-methylbutyl) barbituric acid)

    Vinylbital (5-(1-methylbutyl)-5-vinylbarbituric acid).

    Schedule 3 Part 4 clause 1 Allobarbital: inserted, on 2 September 1996, by section 8(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 3 Part 4 clause 1 Buprenorphine: replaced, on 26 April 1984, by clause 2 of the Misuse of Drugs Order 1984 (SR 1984/101).

    Schedule 3 Part 4 clause 1 Butalbital: inserted, on 2 September 1996, by section 8(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 3 Part 4 clause 1 Ketamine: inserted, on 1 December 2010, by clause 3 of the Misuse of Drugs (Classification of Ketamine) Order 2009 (SR 2009/255).

    Schedule 3 Part 4 clause 1 Secbutabarbital: inserted, on 2 September 1996, by section 8(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 3 Part 4 clause 1 Vinylbital: inserted, on 2 September 1996, by section 8(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

  • 2 The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

  • 3 The esters and ethers of the substances mentioned in this Part and the esters and the ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

  • 4 The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

  • 5 Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4, except a mixture of a derivative of barbituric acid named or described in clause 1 compounded with 1 or more other pharmacologically active ingredients not named or described in clause 1.

    Schedule 3 Part 4 clause 5: amended, on 25 May 1978, by clause 2(1) of the Misuse of Drugs Order 1978 (SR 1978/143).

Part 5

1 The following substances, namely:
  • Alprazolam

    Amfepramone (2-(diethylamino) propiophenone)

    Aminorex

    Barbital (5,5-diethylbarbituric acid)

    Bromazepam

    Brotizolam

    Camazepam

    Chlordiazepoxide

    Clobazam

    Clonazepam

    Clorazepate

    Clotiazepam

    Cloxazolam

    Delorazepam

    Diazepam

    Estazolam

    Ethchlorvynol (ethyl-2-chlorovinylethynyl-carbinol)

    Ethinamate (1-ethynylcyclohexanol carbamate)

    Ethyl loflazepate

    Fludiazepam

    Flunitrazepam

    Flurazepam

    Halazepam

    Haloxazolam

    Ketazolam

    Loprazolam

    Lorazepam

    Lormetazepam

    Mazindol (5-(4-chlorophenyl)-2, 5-dihydro-3H-imidazo [2, 1-a]-isoindol-5-ol)

    Medazepam

    Meprobamate (2-methyl-2-propyl-1,3-propanediol dicarbamate)

    Methylphenobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)

    Methylprylon (3,3-diethyl-5-methylpiperidine-2,4-dione)

    Midazolam

    Nimetazepam

    Nitrazepam

    Nordazepam

    Oxazepam

    Oxazolam

    Pemoline

    Phenobarbital (5-ethyl-5-phenylbarbituric acid)

    Phentermine (2-amino-2-methyl-1-phenylpropane)

    Pinazepam

    Pipradrol (1,1-diphenyl-1-(2-piperidyl)methanol)

    Prazepam

    SPA ((−)-1-dimethylamino-1,2-diphenylethane)

    Temazepam

    Tetrazepam

    Triazolam.

    Schedule 3 Part 5 clause 1 Alprazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Aminorex: inserted, on 30 May 2003, by clause 6 of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

    Schedule 3 Part 5 clause 1 Bromazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Brotizolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Camazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Chlordiazepoxide: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Clobazam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Clonazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Clorazepate: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Clotiazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Cloxazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Delorazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Diazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Ephedrine: repealed, on 8 September 2011, by section 9(2) of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

    Schedule 3 Part 5 clause 1 Estazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Ethyl loflazepate: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Fludiazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Flunitrazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Flurazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Halazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Haloxazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Ketazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Loprazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Lorazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Lormetazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Mazindol: replaced, on 20 December 1984, by clause 2(2) of the Misuse of Drugs Order (No 2) 1984 (SR 1984/315).

    Schedule 3 Part 5 clause 1 Medazepam: inserted, on 1  January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Midazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Nimetazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Nitrazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Nordazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Oxazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Oxazolam: inserted, on 1  January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Pemoline: inserted, on 30 May 2003, by clause 6 of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

    Schedule 3 Part 5 clause 1 Phentermine: inserted, on 16 December 1982, by clause 2(2) of the Misuse of Drugs Order 1982 (SR 1982/259).

    Schedule 3 Part 5 clause 1 Pinazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Prazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Pseudoephedrine: repealed, on 8 September 2011, by section 9(2) of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

    Schedule 3 Part 5 clause 1 Temazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Tetrazepam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

    Schedule 3 Part 5 clause 1 Triazolam: inserted, on 1 January 1999, by clause 2 of the Misuse of Drugs Order 1998 (SR 1998/351).

  • 2 The isomers of the substances mentioned in this Part whenever the existence of such isomers is possible within the specific chemical designation.

  • 3 The esters and ethers of the substances mentioned in this Part and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

  • 4 The salts of the substances mentioned in this Part and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

  • 5 Mixtures of a derivative of barbituric acid named or described in Part 4 compounded with 1 or more other pharmacologically active ingredients not named or described in Part 4.

    Schedule 3 Part 5 clause 5: replaced, on 25 May 1978, by clause 2(2) of the Misuse of Drugs Order 1978 (SR 1978/143).

  • 5A Preparations of propoxyphene, its isomers, esters, and ethers, if any, its salts, and the salts of its isomers, esters, or ethers, if any, for oral use containing not more than the equivalent of 135 milligrams of propoxyphene base per dosage unit or with a concentration of not more than 2.5% in undivided preparations, being preparations whereof none of the other ingredients is a substance named or described in Schedules 1 or 2 or in Parts 1 to 5 of this schedule.

    Schedule 3 Part 5 clause 5A: replaced, on 20 December 1984, by clause 2(3) of the Misuse of Drugs Order (No 2) 1984 (SR 1984/315).

  • 6 Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, clause 4, clause 5 or clause 5A, other than a preparation or mixture named or described in Part 6.

    Schedule 3 Part 5 clause 6: inserted, on 25 May 1978, by clause 2(2) of the Misuse of Drugs Order 1978 (SR 1978/143).

    Schedule 3 Part 5 clause 6: amended, on 16 December 1982, by clause 2(4) of the Misuse of Drugs Order 1982 (SR 1982/259).

Part 6

The following preparations and mixtures, namely:

  • (a) preparations containing any proportion of the following substances or of any salt of any such substance, namely, acetyldihydrocodeine, codeine, dihydrocodeine, ethylmorphine, and pholcodine when:

    • (i) compounded with 1 or more other pharmacologically active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield which would constitute a risk to health; and

    • (ii) containing not more than 100 milligrams of the substance in each dosage unit and with a concentration of not more than 2.5% in undivided preparations:

  • (aa) preparations containing a derivative of barbituric acid named or described in Part 4 or Part 5, in solutions containing not more than 0.5% of that derivative of barbituric acid:

  • (b) preparations of cocaine containing not more than 0.1% of cocaine base, being preparations compounded with 1 or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 or in Parts 1 to 5 of this schedule) in such a way that the preparation has no, or a negligible, risk of abuse, and in such a way that the cocaine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health:

  • (c) preparations of difenoxin containing, per dosage unit, not more than 0.5 mg of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin:

  • (d) preparations of opium or morphine containing not more than 0.2% of morphine, being preparations compounded with 1 or more other pharmacologically active ingredients (none of which are substances named or described in Schedules 1 or 2 or in Parts 1 to 5 of this schedule) in such a way that the opium or the morphine, as the case may be, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health:

  • (e) single dosage units of diphenoxylate containing in each unit not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 25 micrograms of atropine sulphate:

  • (f) liquid preparations of diphenoxylate containing, in each millilitre, not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate:

  • (ff) preparations of propiram containing not more than 100 mg of propiram per dosage unit and compounded with at least the same amount of methylcellulose:

  • (g) ipecacuanha and opium powder containing 10% of opium in powder and 10% of ipecacuanha root in powder intimately mixed with finely powdered lactose:

  • (h) mixtures containing not more than 1 of the preparations specified in paragraphs (a) to (g), being mixtures whereof none of the other ingredients is a substance named or described in Schedules 1 or 2 or in Parts 1 to 5 of this schedule.

    • Schedule 3 Part 6 paragraph (aa): inserted, on 25 May 1978, by clause 2(3) of the Misuse of Drugs Order 1978 (SR 1978/143).

    • Schedule 3 Part 6 paragraph (ff): inserted, on 25 May 1978, by clause 2(4) of the Misuse of Drugs Order 1978 (SR 1978/143).

Part 7

  • Schedule 3 Part 7: inserted, on 13 January 1988, by section 10 of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

Amphetamine analogues, in which the 1-amino-2-phenylethane nucleus carries any of the following radicals, either alone or in combination:

  • (a) 1 or 2 alkyl radicals, each with up to 6 carbon atoms, attached to the nitrogen atom:

  • (b) 1 or 2 methyl radicals, or an ethyl radical, attached to the carbon atom adjacent to the nitrogen atom:

  • (c) a hydroxy radical, attached to the carbon atom adjacent to the benzene ring:

  • (d) any combination of up to 5 alkyl radicals and/or alkoxy radicals and/or alkylamino radicals and/or alkylthio radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals and/or nitro radicals and/or amino radicals, attached to the benzene ring.

Pethidine analogues, in which a 4-phenylpiperidine nucleus carries any of the following radicals, either alone or in combination:

  • (a) an alkyl radical, with up to 6 carbon atoms, attached to the nitrogen atom:

  • (b) a phenalkyl radical, with up to 12 carbon atoms, attached to the nitrogen atom:

  • (c) a phenalkyl radical, as in paragraph (b), with 1 or more alkyl radicals, each with up to 6 carbon atoms, attached to the benzene ring in the phenalkyl radical:

  • (d) an alkylcarbonyloxy or alkoxycarbonyl or hydroxy radical, with up to 6 carbon atoms, attached to the 4 position in the piperidine ring:

  • (e) any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.

Phencyclidine analogues, being chemical compounds with the 1-alkylamino-1-arylcyclohexane structure, with any combination of the following alkylamino and aryl radicals:

  • (a) the alkylamino radical is 1-piperidinyl, 1-pyrrolidinyl, 4-morpholinyl, or any other radical with up to 6 carbon atoms in the alkyl portion:

  • (b) the aryl radical is phenyl, thienyl, pyridinyl, or pyrrolidinyl:

  • (c) the aryl radical, as described in paragraph (b), carries any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals.

Fentanyl analogues, in which the N-[1-(2-phenethyl)-4-piperidyl]aniline nucleus has additional radicals, either alone or in combination, attached as follows:

  • (a) an acetyl, propionyl, butenoyl or butanoyl radical, attached to the aniline nitrogen atom:

  • (b) 1 or more alkyl radicals, with up to 10 carbon atoms in total, attached to the ethyl moeity:

  • (c) any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to each of the benzene rings.

Methaqualone analogues, in which the 3-arylquinazolin-4-one nucleus has additional radicals, either alone or in combination, attached as follows:

  • (a) an alkyl radical, with up to 6 carbon atoms, attached at the 2 position:

  • (b) any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to each of the aryl rings.

DMT (dimethyltryptamine) analogues, in which the 3-(2-aminoethyl)indole nucleus has additional radicals, either alone or in combination, attached as follows:

  • (a) 1 or 2 alkyl radicals, each with up to 6 carbon atoms, including cyclic radicals, attached to the amino nitrogen atom:

  • (b) 1 or 2 methyl groups, or an ethyl group, attached to the carbon atom adjacent to the amino nitrogen atom:

  • (c) any combination of up to 5 alkyl radicals and/or alkoxy radicals (each with up to 6 carbon atoms, including cyclic radicals) and/or halogen radicals, attached to the benzene ring.

  • Schedule 3 Part 7 Amphetamine analogues paragraph (d): amended, on 9 August 2011, by section 9(3) of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

  • Schedule 3 Part 7 Fentanyl analogues paragraph (c): amended, on 2 September 1996, by section 8(4) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).